Menopause Treatment in India Market Share, Trend & Forecast 2034

Q: How big is the menopause treatment industry in India?

India's industry is set to reach US$ 78.0 million in 2024. Read Report

Request Methodology

India Menopause Treatment Industry Outlook from 2024 to 2034

India's menopause treatment industry is expected to grow at a CAGR of 6.6% through 2034. The industry is predicted to increase from US$ 78.0 million in 2024 to US$ 147.3 million by 2034. The menopause treatment industry in India was valued at US$ 72.7 million in 2023 and is anticipated to exhibit a y-o-y growth of 7.2% in 2024.

Attributes	Key Insights
Base Value (2023)	US$ 72.7 million
Estimated India Menopause Treatment Industry Size (2024)	US$ 78.0 million
Value of the Menopause Treatment in India (2034)	US$ 147.3 million
Value-based CAGR (2024 to 2034)	6.6%

Increasing public awareness of menopause treatment’s benefits and growing prevalence of menopausal symptoms are the factors pushing the industry expansion. The menopause treatment industry in India is undergoing a transformative shift, marked by a growing acceptance of hormone replacement therapy (HRT) among women. This trend reflects individual health choices and presents a substantial industry opportunity.

Ongoing clinical trials in India signify a commitment to innovative solutions in the menopause treatment industry. The influx of treatments addresses current industry needs and propels the industry's growth, creating a competitive landscape and stimulating further innovations.

Increasing healthcare infrastructure and growing emphasis on women's health are expected to further surge the menopause treatment industry. The menopause therapy industry in India is expected to rise due to increasing demand for personalized medicine, which tailors treatment to each patient's unique issues.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical India Menopause Treatment Industry Growth Outlook Vs. 2024 to 2034

India's menopause treatment industry recorded a historical CAGR of 5.8% from 2019 to 2023. The industry value for India's menopause treatment reached US$ 68.1 million in 2022 from US$ 54.8 million in 2018.

During 2019 and 2023, there has been a significant shift in societal attitudes toward menopause, leading to increased awareness. Efforts by organizations and healthcare professionals to educate women about menopause have contributed to growth of the menopause treatment industry.

Supportive policies and initiatives from government bodies and healthcare organizations have augmenting a conducive environment for the development of menopause treatment. These measures include funding for research, awareness campaigns, and inclusion of menopausal health in public health programs.

Looking forward, the future of the menopause treatment industry anticipates a gradual acceleration of growth. Continued research & development efforts are expected to yield personalized and more effective treatments while integrating digital health and telemedicine is poised to enhance accessibility.

Increasing aging population contributes to sustained industry growth, with an increasing number of women entering menopause in India. Furthermore, the trend toward consumer empowerment and informed decision-making is likely to shape the industry by creating diverse treatment options.

These historic and futuristic factors create a dynamic landscape, offering opportunities for pharmaceutical companies, healthcare providers, and researchers to contribute to women's health during the menopausal transition.

Insights into Lucrative Opportunities Propelling Menopause Treatment in India

A significant opportunity for expansion of the menopause drug industry lies in the notable increase in the number of menopausal drugs advancing through drug development pipelines of key manufacturers. This surge in research and development efforts signifies a promising trajectory for the industry.

The influx of innovative treatments not only addresses the current unmet needs in the industry but also supports a competitive landscape, stimulating further innovations in the menopause treatment industry. Increasing momentum in drug development activities represents a key catalyst for the growth and evolution of the menopause drug industry in India.

Exploring and advancing natural or herbal treatment options for menopausal symptoms is set to create opportunities for leading companies in the drug sector. This avenue of development holds the promise of providing therapeutic alternatives with fewer side effects, catering to increasing demand for more holistic and gentle approaches to menopause management.

The ‘organic’ trend also aligns with a broader cultural shift toward wellness and preventive healthcare, where consumers are increasingly inclined to explore alternative and natural remedies. Leading manufacturers in the menopausal pharmaceutical drugs sector are using this opportunity to develop evidence-based, scientifically validated natural treatments, ensuring safety and efficacy.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Overview of Factors Affecting the Menopause Treatment Industry

The prominence of traditional medicines like Shatavari and Ashwagandha, coupled with the availability of Ayurvedic treatment options, has posed a formidable challenge to growth of prescription (Rx) and over-the-counter (OTC) drugs for menopause treatment. These herbal remedies, deeply rooted in Ayurveda, have gained substantial popularity among women seeking alternative and holistic approaches to manage menopausal symptoms.

Ayurvedic treatments, often perceived as natural and with fewer side effects, are increasingly preferred by those who may be wary of the potential risks associated with conventional hormonal therapies. This shift in consumer preferences toward traditional medicines poses a dual challenge for the Rx and OTC menopause drug industry.

The shift is expected to diminish the share of pharmaceutical menopause treatments as women explore alternative options deeply ingrained in Indian cultural practices. Furthermore, the perception of herbal remedies as safer and more aligned with holistic well-being influences women to opt for Ayurvedic alternatives. It helps in potentially reducing the demand for prescription and over-the-counter menopause drugs.

Comparative View of Adjacent Industries

The following section provides key attributes of the industries related to India’s menopause treatment. These include the skincare treatment and over-the-counter pain medication industries.

Drivers and trends are thoroughly analyzed to find business opportunities in all these industries. This can provide deeper insights that help develop unique differentiating strategies to pursue growth and opportunity in India’s menopause treatment industry. Growth of these mentioned industries is closely tied to healthcare and cosmetic industries.

India Menopause Treatment Industry Analysis:

Attributes	Industry Analysis of Menopause Treatment in India
CAGR (2024 to 2034)	6.6%
Opportunity for the Menopause Treatment in India	Women in India are increasingly seeking natural and herbal remedies for menopausal symptoms, citing concerns about potential side effects of conventional medications, leading to a surge in demand.
Trends in the India Menopause Treatment Industry	Indian women are becoming more educated about menopause symptoms through healthcare practitioners, media campaigns, and online resources, leading to improved treatment options.

Skincare Treatment Industry Outlook:

Attributes	Skincare Treatment Demand Outlook
CAGR (2024 to 2034)	5.4%
Growth Factor	Rising consumer awareness, technological innovations, and increasing disposable income are surging demand for skincare treatment.
Key Trend	Growing grooming awareness among men and evolving societal norms regarding male self-care is a key trend in the industry.

Over-the-counter Pain Medication Sales Forecast:

Attributes	Over-the-counter Pain Medication Sales Forecast
CAGR (2024 to 2034)	4.0%
Growth Factor	Chronic pain disorders are becoming prevalent worldwide, escalating the demand for over-the-counter pain medication.
Key Trend	Rising older adults looking for ways to manage their discomfort surge the adoption of over-the-counter pain medication.

Country-wise Insights

The table below shows the estimated growth rates of leading countries. Northern India, Northeast India, and Western India are set to record high CAGRs of 7.2%, 8.6%, and 7.8% respectively, through 2034.

Region	Value CAGR (2024 to 2034)
Northern India	7.2%
Northeast India	8.6%
Central India	5.3%
Eastern India	5.0%
Western India	7.8%
Southern India	6.3%

Increasing Collaborations between Companies to Surge Demand in Southern India

Southern India dominates the industry with a 31.4% share in 2023 and is projected to continue experiencing stable growth throughout the forecast period. Southern India hosts research and development hubs, contributing to the innovation in menopause treatments. Collaborations between pharmaceutical companies, research institutions, and healthcare providers lead to the introduction of novel therapeutic options, propelling industry growth.

Cultural shifts in Southern India have witnessed more open conversations about women's health, including menopause. This cultural change has increased awareness and a willingness to explore treatment options, positively impacting the menopause treatment industry.

Growing Urbanization in Western India Fuels Industry Expansion

Western India takes center stage in the menopause treatment industry, claiming a noteworthy industry share of 20.0%. Rapid urbanization and lifestyle changes in Western India have led to an increased prevalence of menopausal symptoms. Demand for effective treatment options is surging as women in urban areas are more aware and proactive about managing their health during the menopausal transition.

The relatively higher socioeconomic status of individuals in Western India allows for increased affordability and access to advanced menopause treatments. This economic stability contributes to a higher adoption rate of hormone replacement therapies and other specialized interventions.

Eastern India to be the Next-door Opportunity for the Manufacturers

In 2023, Eastern India held a significant industry share of 18.2%, asserting its dominance, and is anticipated to maintain robust growth over the forecast period. Growth of the menopause treatment industry in Eastern India is influenced by the region's rising healthcare infrastructure. Improved access to healthcare facilities and specialized clinics catering to menopausal health contributes to heightened awareness and treatment options in Eastern India.

Category-wise Insights

The section below shows the hormone therapy segment leading in terms of product. It is estimated to thrive at a 7.4% CAGR between 2024 and 2034. Based on route of administration, the oral segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 7.3% during the forecast period.

Widespread Use of Hormone Therapy in Menopause Treatment

Products	Value CAGR (2024 to 2034)
Hormone Therapy	7.4%
Non-Hormonal Therapy	6.1%
Nutritional Supplements	1.9%

Hormone therapy dominated the industry with a 55.8% share in 2023 and is projected to continue experiencing high growth throughout the forecast period. Hormone therapy dominates the menopause industry by providing effective relief from symptoms like hot flashes and mood swings.

Hormone therapy addresses hormonal imbalances, making it a preferred choice among women seeking comprehensive and targeted solutions during the menopausal transition, thereby augmenting its widespread adoption.

Oral Segment is Leading as the Top Route of Administration

Route of Administration	Value CAGR (2024 to 2034)
Topical	6.0%
Injectable	4.4%
Oral	7.3%

The oral segment held 64.2% industry share in 2023 and is projected to continue experiencing steady growth throughout the forecast period. Oral medications lead the industry due to their convenience and ease of administration.

Women prefer oral formulations for hormone replacement therapy, contributing to high patient adherence. The simplicity and familiarity of oral intake make it a prominent and accessible choice in the menopause treatment landscape.

Rx Market Status to Dominate the Menopause Treatment Industry

Market Status	Value CAGR (2024 to 2034)
Rx	6.8%
OTC	4.4%

Based on market status, the Rx segment held 94.2% industry share in 2023. Prescription medications play a pivotal role in shaping the menopause industry, ensuring that treatment plans are tailored to individual needs.

The expertise of healthcare professionals prescribing specific medications addresses diverse symptom profiles, offering personalized solutions. This approach establishes prescription medications as key drivers in the menopause treatment sector.

Hospital Segment to Lead the Distribution Channel Category

Distribution Channel	Value CAGR (2024 to 2034)
Hospitals	6.5%
Specialty Clinics	8.0%
Online Sales/Online Pharmacy Platforms	9.4%

Hospitals will likely dominate the industry with a 43.2% share in 2023. Hospitals are at the forefront of menopause treatment, offering comprehensive healthcare services in India.

Specialized menopause clinics within hospitals provide a multidisciplinary approach, combining medical expertise, counseling, and supportive care. The institutional infrastructure and accessibility make hospitals central to effectively managing menopausal symptoms in India.

Competitive Landscape

In the dynamic landscape of the menopause treatment industry, companies are strategically emphasizing collaboration & partnerships and continuously focusing on product approval. These initiatives reflect the industry's commitment to innovation, addressing evolving industry demands, and staying competitive. Instances of key developmental strategies by industry players in India’s menopause treatment industry are given below:

On December 02, 2022, Zydus Lifesciences Ltd. received final approval from the United States Food and Drug Administration (USFDA) to market the Estradiol Transdermal System. The company stated that this approval treats moderate to severe menopausal symptoms.
In 2022, Emcure launched the EmWocal campaign to raise awareness of breastfeeding, anemia, and menstruation.

Key Companies Profiled

Pfizer Inc.
Bayer AG
Serum Institute of India
Intas Pharmaceuticals Limited
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
Torrent Pharmaceuticals Ltd.
Koye Pharmaceuticals Pvt. Ltd.
Emcure Pharmaceuticals
Vitabiotics
Himalaya Global Holdings Ltd.
Nature's Way Brands
Bharat Serums and Vaccines Limited (BSV)
Nordic Naturals
ZeroHarm

Key Coverage in the Menopause Treatment Industry in India Report

Adjacent Study on Menopause Management Industry, Menopausal Symptom Treatment Industry, Indian Menopause Medication Industry, and Menopause Support Supplement Industry
Analysis of Menopausal Therapy Industry in India
Industry Dynamics of Menopause Relief Products
Overview of Hormone Replacement Therapy Industry in India
Emerging Trends in Menopause Management
Impact of Menopausal Symptom Treatment Options
Future Outlook for Menopause Support Supplements
Sales of Menopause Treatment Products
Hormone Replacement Therapy Industry in India

Menopause Treatment Industry Segmentation by Category

By Product:

Hormone Therapy
- Combination
- Tibolone
- Progestin-only Medicines
- Estrogen-only Medicines
Non-hormonal Therapy
- Gabapentinoids
- Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Others
Nutritional Supplements
- Multi-vitamin Supplements
- Phytoestrogen Supplement
- Antioxidant Supplements
- Other Supplements

By Route of Administration:

Topical
Injectable
Oral

By Market Status:

By Distribution Channel:

Hospitals
Specialty Clinics
Retail Pharmacies
Drug Stores
Online Sales/Online Pharmacy Platforms

By Region:

Northern India
Northeast India
Central India
Eastern India
Western India
Southern India

Frequently Asked Questions

How big is the menopause treatment industry in India?

India's industry is set to reach US$ 78.0 million in 2024.

What is the forecast for the menopause treatment industry?

Demand in India is slated to rise at a 6.6% CAGR through 2034.

What is the outlook for the menopause treatment industry in India?

The target industry is set to reach US$ 147.3 million in 2034.

Which product will garner significant value share by 2024?

Hormone therapy segment is expected to garner a significant value share by 2024.

What was the value of the menopause treatment industry in 2023?

India’s menopause treatment industry was valued at US$ 72.7 million in 2023.

Table of Content

1. Executive Summary

    1.1. Industry Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Side Trends

    1.4. Analysis and Recommendations

2. Industry Overview

    2.1. Industry Coverage / Taxonomy

    2.2. Industry Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Trends

    3.1. Key Trends

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Understanding Menopause

    4.2. Product Adoption Analysis, By Region

    4.3. Prevalence of Menopause in India

    4.4. Alternative Therapies to HRT

    4.5. Legal Requirements and Frameworks in the India

    4.6. PESTLE Analysis

    4.7. Porter’s Analysis

    4.8. Unmet Needs and Opportunities

5. Industry Background

    5.1. Macro-Economic Factors

        5.1.1. Pharmaceutical Industry Outlook

        5.1.2. R&D Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Prevalence of Menopause

        5.2.2. Adoption and Availability of Treatment

        5.2.3. Dosage Pattern

        5.2.4. Overall Therapy Cost

        5.2.5. Growing Demand for Non-Hormonal Therapies

        5.2.6. Rising Demand for Natural and Herbal Remedies

        5.2.7. Increasing Research and Development

        5.2.8. Government Initiatives and Regulations

    5.3. Industry Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Industry Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034

    6.1. Historical Industry Value (US$ million) Analysis 2019 to 2023

    6.2. Current and Future Industry Value (US$ million) Projections, 2024 to 2034

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    7.1. Introduction / Key Findings

    7.2. Historical Industry Size (US$ million) Analysis, By Product, 2019 to 2023

    7.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Product, 2024 to 2034

        7.3.1. Hormone Therapy

            7.3.1.1. Combination

            7.3.1.2. Tibolone

            7.3.1.3. Progestin-only Medicines

            7.3.1.4. Estrogen-only Medicines

        7.3.2. Non-hormonal Therapy

            7.3.2.1. Gabapentinoids

            7.3.2.2. Serotonin-norepinephrine Reuptake Inhibitors (SNRI)

            7.3.2.3. Selective Serotonin Reuptake Inhibitors (SSRI)

            7.3.2.4. Others

        7.3.3. Nutritional Supplements

            7.3.3.1. Multi-vitamin Supplements

            7.3.3.2. Phytoestrogen Supplement

            7.3.3.3. Antioxidant Supplements

            7.3.3.4. Other Supplements

    7.4. Industry Attractiveness Analysis, By Product

8. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

    8.1. Introduction / Key Findings

    8.2. Historical Industry Size (US$ million) Analysis, By Route of Administration, 2019 to 2023

    8.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Route of Administration, 2024 to 2034

        8.3.1. Topical

        8.3.2. Injectable

        8.3.3. Oral

    8.4. Industry Attractiveness Analysis, By Route of Administration

9. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

    9.1. Introduction / Key Findings

    9.2. Historical Industry Size (US$ million) Analysis, By Market Status, 2019 to 2023

    9.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Market Status, 2024 to 2034

        9.3.1. Rx

        9.3.2. OTC

    9.4. Industry Attractiveness Analysis, By Route of Administration

10. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Industry Size (US$ million) Analysis, By Distribution Channel, 2019 to 2023

    10.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Distribution Channel, 2024 to 2034

        10.3.1. Hospitals

        10.3.2. Specialty Clinics

        10.3.3. Retail Pharmacies

        10.3.4. Drug Stores

        10.3.5. Online Sales/Online Pharmacy Platforms

    10.4. Industry Attractiveness Analysis, By Distribution Channel

11. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region

    11.1. Introduction

    11.2. Historical Industry Size (US$ million) Analysis, By Region, 2019 to 2023

    11.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Region, 2024 to 2034

        11.3.1. Northern India

        11.3.2. Northeast India

        11.3.3. Central India

        11.3.4. Eastern India

        11.3.5. Western India

        11.3.6. Southern India

    11.4. Industry Attractiveness Analysis, By Region

12. Northern Industry Analysis 2019 to 2023 and Forecast 2024 to 2034

    12.1. Introduction

    12.2. Historical Industry Size (US$ million) Analysis, By Industry, 2019 to 2023

    12.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Industry, 2024 to 2034

        12.3.1. By State

            12.3.1.1. New Delhi

            12.3.1.2. Punjab

            12.3.1.3. Himachal Pradesh

            12.3.1.4. Haryana

            12.3.1.5. Jammu & Kashmir

            12.3.1.6. Uttarakhand

        12.3.2. By Product

        12.3.3. By Route of Administration

        12.3.4. By Market Status

        12.3.5. By Distribution Channel

    12.4. Industry Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product

        12.4.3. By Route of Administration

        12.4.4. By Market Status

        12.4.5. By Distribution Channel

13. Northeast Industry Analysis 2019 to 2023 and Forecast 2024 to 2034

    13.1. Introduction

    13.2. Historical Industry Size (US$ million) Analysis, By Industry, 2019 to 2023

    13.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Industry, 2024 to 2034

        13.3.1. By State

            13.3.1.1. Arunachal Pradesh

            13.3.1.2. Assam

            13.3.1.3. Nagaland

            13.3.1.4. Manipur

            13.3.1.5. Mizoram

            13.3.1.6. Tripura

            13.3.1.7. Meghalaya

        13.3.2. By Product

        13.3.3. By Route of Administration

        13.3.4. By Market Status

        13.3.5. By Distribution Channel

    13.4. Industry Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By Route of Administration

        13.4.4. By Market Status

        13.4.5. By Distribution Channel

14. Central Industry Analysis 2019 to 2023 and Forecast 2024 to 2034

    14.1. Introduction

    14.2. Historical Industry Size (US$ million) Analysis, By Industry, 2019 to 2023

    14.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Industry, 2024 to 2034

        14.3.1. By State

            14.3.1.1. Madhya Pradesh

            14.3.1.2. Chhattisgarh

            14.3.1.3. Uttar Pradesh

        14.3.2. By Product

        14.3.3. By Route of Administration

        14.3.4. By Market Status

        14.3.5. By Distribution Channel

    14.4. Industry Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Route of Administration

        14.4.4. By Market Status

        14.4.5. By Distribution Channel

15. Eastern Industry Analysis 2019 to 2023 and Forecast 2024 to 2034

    15.1. Introduction

    15.2. Historical Industry Size (US$ million) Analysis, By Industry, 2019 to 2023

    15.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Industry, 2024 to 2034

        15.3.1. By State

            15.3.1.1. Western India Bengal

            15.3.1.2. Odisha

            15.3.1.3. Jharkhand

            15.3.1.4. Bihar

            15.3.1.5. Sikkim

        15.3.2. By Product

        15.3.3. By Route of Administration

        15.3.4. By Market Status

        15.3.5. By Distribution Channel

    15.4. Industry Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Route of Administration

        15.4.4. By Market Status

        15.4.5. By Distribution Channel

16. Western Industry Analysis 2019 to 2023 and Forecast 2024 to 2034

    16.1. Introduction

    16.2. Historical Industry Size (US$ million) Analysis, By Industry, 2019 to 2023

    16.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Industry, 2024 to 2034

        16.3.1. By State

            16.3.1.1. Maharashtra

            16.3.1.2. Gujarat

            16.3.1.3. Rajasthan

            16.3.1.4. Goa

        16.3.2. By Product

        16.3.3. By Route of Administration

        16.3.4. By Market Status

        16.3.5. By Distribution Channel

    16.4. Industry Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Route of Administration

        16.4.4. By Market Status

        16.4.5. By Distribution Channel

17. Southern Industry Analysis 2019 to 2023 and Forecast 2024 to 2034

    17.1. Introduction

    17.2. Historical Industry Size (US$ million) Analysis, By Industry, 2019 to 2023

    17.3. Current and Future Industry Size (US$ million) Analysis and Forecast By Industry, 2024 to 2034

        17.3.1. By State

            17.3.1.1. Tamil Nadu

            17.3.1.2. Kerala

            17.3.1.3. Karnataka

            17.3.1.4. Andhra Pradesh

            17.3.1.5. Telangana

        17.3.2. By Product

        17.3.3. By Route of Administration

        17.3.4. By Market Status

        17.3.5. By Distribution Channel

    17.4. Industry Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Route of Administration

        17.4.4. By Market Status

        17.4.5. By Distribution Channel

18. Industry Share Analysis of Top Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Deep Dive

        19.2.1. Pfizer Inc.

            19.2.1.1. Overview

            19.2.1.2. Product Portfolio

            19.2.1.3. Sales Footprint

            19.2.1.4. Key Financials

            19.2.1.5. SWOT Analysis

            19.2.1.6. Strategy Overview

                19.2.1.6.1. Marketing Strategy

                19.2.1.6.2. Product Strategy

                19.2.1.6.3. Channel Strategy

        19.2.2. Bayer AG

        19.2.3. Serum Institute of India

        19.2.4. Intas Pharmaceuticals Limited

        19.2.5. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

        19.2.6. Torrent Pharmaceuticals Ltd

        19.2.7. Koye Pharmaceuticals Pvt. Ltd

        19.2.8. Emcure Pharmaceuticals

        19.2.9. Vitabiotics

        19.2.10. Himalaya Global Holdings Ltd.

        19.2.11. Nature's Way Brands

        19.2.12. Bharat Serums and Vaccines Limited (BSV)

        19.2.13. Nordic Naturals

        19.2.14. ZeroHarm

20. Assumptions and Acronyms Used

21. Research Methodology

List of Tables

Table 1: Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 2: Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 3: Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 4: Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 5: Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 6: Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 7: Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 8: Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 9: Northern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034 by States

Table 10: Northern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 11: Northern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 12: Northern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 13: Northern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 14: Northern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 15: Northern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 16: Northern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 17: Northern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 18: Northeast Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By States

Table 19: Northeast Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 20: Northeast Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 21: Northeast Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 22: Northeast Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 23: Northeast Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 24: Northeast Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 25: Northeast Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 26: Northeast Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 27: Central Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034 By, States

Table 28: Central Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 29: Central Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 30: Central Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 31: Central Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 32: Central Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 33: Central Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 34: Central Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 35: Central Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 36: Eastern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By States

Table 37: Eastern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 38: Eastern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 39: Eastern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 40: Eastern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 41: Eastern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 42: Eastern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 43: Eastern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 44: Eastern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 45: Western Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By States

Table 46: Western Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 47: Western Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 48: Western Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 49: Western Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 50: Western Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 51: Western Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 52: Western Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 53: Western Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 54: Southern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By States

Table 55: Southern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 56: Southern Industry Size (US$ million) Analysis 2019 to 2023, and Forecast 2024 to 2034, By Product

Table 57: Southern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 58: Southern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration

Table 59: Southern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 60: Southern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Market Status

Table 61: Southern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

Table 62: Southern Industry Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

List of Charts

Figure 1: Industry Split, By Product, 2024 (E)

Figure 2: Industry Split, By Route of Administration, 2024 (E)

Figure 3: Industry Split, By Market Status, 2024 (E)

Figure 4: Industry Split, By Distribution Channel, 2024 (E)

Figure 5: Industry Split, By Region, 2024 (E)

Figure 6: Industry Value Analysis (US$ million), 2019 to 2023

Figure 7: Industry Value Forecast (US$ million), 2024 to 2034

Figure 8: Industry Absolute $ Opportunity, 2024 to 2034

Figure 9: Industry Share Analysis (%), By Product, 2024(E) to 2034(F)

Figure 10: Industry Y-o-Y Analysis (%), By Product, 2024 to 2034

Figure 11: Industry Attractiveness Analysis, By Product, 2024 to 2034

Figure 12: Industry Share Analysis (%), By Route of Administration, 2024 (E) to 2034 (F)

Figure 13: Industry Y-o-Y Analysis (%), By Route of Administration, 2024 to 2034

Figure 14: Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 15: Industry Share Analysis (%), By Market Status, 2024 (E) to 2034 (F)

Figure 16: Industry Y-o-Y Analysis (%), By Market Status, 2024 to 2034

Figure 17: Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 18: Industry Share Analysis (%), By Distribution Channel, 2024 (E) to 2034 (F)

Figure 19: Industry Y-o-Y Analysis (%), By Distribution Channel, 2024 to 2034

Figure 20: Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 21: Industry Share Analysis (%), By Region, 2024 (E) to 2034 (F)

Figure 22: Industry Y-o-Y Analysis (%), By Region, 2024 to 2034

Figure 23: Industry Attractiveness Analysis, By Region, 2024 to 2034

Figure 24: Northern Industry Value Share, By Product Type (2024 E)

Figure 25: Northern Industry Value Share, By Route of Administration (2024 E)

Figure 26: Northern Industry Value Share, By Distribution Channel (2024 E)

Figure 27: Northern Industry Value Share, By States (2024 E)

Figure 28: Northern Industry Value Analysis (US$ million), 2019 to 2023

Figure 29: Northern Industry Value Forecast (US$ million), 2024 to 2034

Figure 30: Northern Industry Attractiveness Analysis, By Product Type, 2024 to 2034

Figure 31: Northern Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 32: Northern Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 33: Northern Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 34: Northern Industry Attractiveness Analysis, By States, 2024 to 2034

Figure 35: Northeast Industry Value Share, By Product Type (2024 E)

Figure 36: Northeast Industry Value Share, By Route of Administration (2024 E)

Figure 37: Northeast Industry Value Share, By Market Status (2024 E)

Figure 38: Northeast Industry Value Share, By Distribution Channel (2023 A)

Figure 39: Northeast Industry Value Share, By States (2023 A)

Figure 40: Northeast Industry Value Analysis (US$ million), 2019 to 2023

Figure 41: Northeast Industry Value Forecast (US$ million), 2024 to 2034

Figure 42: Northeast Industry Attractiveness Analysis, By Product Type, 2024 to 2034

Figure 43: Northeast Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 44: Northeast Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 45: Northeast Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 46: Northeast Industry Attractiveness Analysis, By States, 2024 to 2034

Figure 47: Central Industry Value Share, By Product Type (2024 E)

Figure 48: Central Industry Value Share, By Route of Administration (2024 E)

Figure 49: Central Industry Value Share, By Market Status (2024 E)

Figure 50: Central Industry Value Share, By Distribution Channel (2024 E)

Figure 51: Central Industry Value Share, By States (2024 E)

Figure 52: Central Industry Value Analysis (US$ million), 2019 to 2023

Figure 53: Central Industry Value Forecast (US$ million), 2024 to 2034

Figure 54: Central Industry Attractiveness Analysis, By Product Type, 2024 to 2034

Figure 55: Central Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 56: Central Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 57: Central Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 58: Central Industry Attractiveness Analysis, By States, 2024 to 2034

Figure 59: Eastern Industry Value Share, By Product Type (2024 E)

Figure 60: Eastern Industry Value Share, By Route of Administration (2024 E)

Figure 61: Eastern Industry Value Share, By Market Status (2024 E)

Figure 62: Eastern Industry Value Share, By Distribution Channel (2024 E)

Figure 63: Eastern Industry Value Share, By States (2024 E)

Figure 64: Eastern Industry Value Analysis (US$ million), 2019 to 2023

Figure 65: Eastern Industry Value Forecast (US$ million), 2024 to 2034

Figure 66: Eastern Industry Attractiveness Analysis, By Product Type, 2024 to 2034

Figure 67: Eastern Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 68: Eastern Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 69: Eastern Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 70: Eastern Industry Attractiveness Analysis, By States, 2024 to 2034

Figure 71: Western Industry Value Share, By Product Type (2024 E)

Figure 72: Western Industry Value Share, By Route of Administration (2024 E)

Figure 73: Western Industry Value Share, By Market Status (2024 E)

Figure 74: Western Industry Value Share, By Distribution Channel (2024 E)

Figure 75: Western Industry Value Share, By States (2024 EA)

Figure 76: Western Industry Value Analysis (US$ million), 2019 to 2023

Figure 77: Western Industry Value Forecast (US$ million), 2024 to 2034

Figure 78: Western Industry Attractiveness Analysis, By Product Type, 2024 to 2034

Figure 79: Western Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 80: Western Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 81: Western Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 82: Western Industry Attractiveness Analysis, By States, 2024 to 2034

Figure 83: Southern Industry Value Share, By Product Type (2024 E)

Figure 84: Southern Industry Value Share, By Route of Administration (2024 E)

Figure 85: Southern Industry Value Share, By Market Status (2024 E)

Figure 86: Southern Industry Value Share, By Distribution Channel (2024 E)

Figure 87: Southern Industry Value Share, By States (2024 EA)

Figure 88: Southern Industry Value Analysis (US$ million), 2019 to 2023

Figure 89: Southern Industry Value Forecast (US$ million), 2024 to 2034

Figure 90: Southern Industry Attractiveness Analysis, By Product Type, 2024 to 2034

Figure 91: Southern Industry Attractiveness Analysis, By Route of Administration, 2024 to 2034

Figure 92: Southern Industry Attractiveness Analysis, By Market Status, 2024 to 2034

Figure 93: Southern Industry Attractiveness Analysis, By Distribution Channel, 2024 to 2034

Figure 94: Southern Industry Attractiveness Analysis, By States, 2024 to 2034

March 2024

REP-GB-19313

326 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Menopause Treatment Industry Analysis in India

Analyzing Menopause Treatment Demand Outlook in India by Hormone Therapy and Non-hormonal Therapy, 2024 to 2034